• $198,856.00
    Market Cap
  • -92.07%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
0
N/A
0
N/A
0
N/A
0
N/A
Research and Development Expense
-222,363
-51.92%
-462,459
+137.88%
-194,406
-24.74%
-258,297
-0.12%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
344,476
-46.48%
643,677
+2.23%
629,629
-21.49%
801,952
+44.82%
Operating Profit
-344,476
-46.48%
-643,677
+2.23%
-629,629
-21.49%
-801,952
+44.82%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-59,391
-43.75%
-105,589
-22.16%
-135,654
-35.06%
-208,892
+301.57%
Interest Income and Expense and Net
-59,391
-43.75%
-105,589
-22.16%
-135,654
-35.06%
-208,892
+301.57%
Total Nonoperating Income and Expense
288,379
+297.97%
-145,670
+40.22%
-103,888
-60.95%
-266,032
+143.57%
Income before Taxes
-344,476
-46.48%
-643,677
+2.23%
-629,629
-21.49%
-801,952
+44.82%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-56,097
-92.89%
-789,347
+7.61%
-733,517
-31.32%
-1.1M
+61.09%
Net Income from Continuing Operations Applicable to Common
-56,097
-92.89%
-789,347
+7.61%
-733,517
-31.32%
-1.1M
+61.09%
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
-0.08
+60.00%
Diluted EPS and Net Income
0.00
N/A
N/A
N/A
N/A
N/A
-0.08
+60.00%
Basic Weighted Average Shares
13.9M
+2.70%
13.5M
+1.72%
13.3M
+0.07%
13.3M
+0.96%
Diluted Weighted Average Shares
13.9M
+2.70%
13.5M
+1.72%
13.3M
+0.07%
13.3M
+0.96%
Balance Sheet
Cash and Cash Equivalents
659
+56.90%
420
-86.31%
3,069
-91.25%
35,065
-39.16%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
659
+56.90%
420
-86.31%
3,069
-91.25%
35,065
-39.16%
Total Current Assets
659
+56.90%
420
-86.31%
3,069
-91.25%
35,065
-39.16%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
659
+56.90%
420
-86.31%
3,069
-91.25%
35,065
-39.16%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
286,000
+53.78%
185,974
-39.67%
308,247
-2.66%
316,685
+44.85%
Total Current Liabilities
432,358
-67.34%
1.3M
+3.23%
1.3M
+12.70%
1.1M
+51.31%
Total Long-Term Debt
10,000
-87.50%
80,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
13,149
-92.03%
164,998
N/A
0
-100.00%
73,099
-67.82%
Total Liabilities
445,507
-70.07%
1.5M
+16.09%
1.3M
+12.70%
1.1M
+51.31%
Retained Earnings
-10.4M
+0.54%
-10.3M
+8.28%
-9.5M
+8.33%
-8.8M
+13.81%
Total Stockholders Equity
-444,848
-70.11%
-1.5M
+16.34%
-1.3M
+16.01%
-1.1M
+58.82%
Total Shares Outstanding
124.1M
+809.45%
13.6M
+1.56%
13.4M
+1.13%
13.3M
0.00%
Cash Flow
Cash from Operating Activities
-61,761
-10.03%
-68,649
-34.30%
-104,496
-14.74%
-122,567
-44.39%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
62,000
-6.06%
66,000
-8.97%
72,500
-27.50%
100,000
-52.61%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-10,397.96%
-77.02%
-45,247.75%
+1,076.17%
-3,847.05%
+66.95%
-2,304.25%
+214.41%
Return on Equity
5.80%
-89.83%
57.04%
-7.38%
61.59%
-48.18%
118.86%
+7.79%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.002
+400.00%
0.0003
-87.50%
0.002
-92.21%
0.03
-59.79%
Cash Ratio
0.002
+400.00%
0.0003
-87.50%
0.002
-92.21%
0.03
-59.79%
Debt-to-Equity Ratio
-0.67
+272.36%
-0.18
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
449.17
-29.07%
633.27
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow